# EDGAR Filing Document

**Accession Number:** 0001819704
**File Stem:** 0001104659-23-004608
**Filing Date:** 2023-1
**Character Count:** 27674
**Document Hash:** 37c8d3e9a1efef4f622efbe3c781774c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-004608.hdr.sgml**: 20230118

**ACCESSION NUMBER**: 0001104659-23-004608

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 11

**CONFORMED PERIOD OF REPORT**: 20230118

**FILED AS OF DATE**: 20230118

**DATE AS OF CHANGE**: 20230118

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Medirom Healthcare Technologies Inc.
- **CENTRAL INDEX KEY:** 0001819704
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PERSONAL SERVICES [7200]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** M0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39809
- **FILM NUMBER:** 23534584

**BUSINESS ADDRESS:**
- **STREET 1:** 2-3-1 DAIBA, MINATO-KU
- **CITY:** TOKYO
- **STATE:** M0
- **ZIP:** 135-0091
- **BUSINESS PHONE:** 81-3-6721-7364

**MAIL ADDRESS:**
- **STREET 1:** 2-3-1 DAIBA, MINATO-KU
- **CITY:** TOKYO
- **STATE:** M0
- **ZIP:** 135-0091

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of January,** **2023**

**Commission File Number 001-39809**

**MEDIROM** **HEALTHCARE TECHNOLOGIES INC.**

(Translation of registrant's name into English)

**2-3-1 Daiba, Minato-ku<br> Tokyo 135-0091, Japan**

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

⌧ Form 20-F ◻ Form 40-F

**INFORMATION CONTAINED IN THIS FORM 6-K REPORT**

*<u>Issuance of Press Release; Unaudited, Preliminary Financial Results</u>*

On January 18, 2023, MEDIROM Healthcare Technologies Inc. (the "Company") issued a press release announcing its unaudited, preliminary financial results for the year ended December 31, 2022, prepared in accordance with Japanese GAAP ("JGAAP").

A copy of this press release is being furnished as Exhibit 99.1 to this Report on Form 6-K (this "Form 6-K'). These preliminary financial results and management's estimates included in such press release are unreviewed, unaudited, and preliminary, are prepared solely in accordance with JGAAP, have not been reviewed or audited under U.S. GAAP, and are based solely on information available to the management of the Company and management's assumptions and expectations as of the date of this press release, which remain subject to change. Actual results for the year ended December 31, 2022 remain subject to the completion of management's reviews and reconciliations and/or adjustments under U.S. GAAP, the Company's other financial closing procedures, and the audit by the independent auditor in accordance with U.S. GAAP, and may differ from these estimated preliminary results due to the completion of the Company's financial closing procedures, the audit under U.S. GAAP, and other developments that may arise during the audit process. Accordingly, undue reliance shall not be placed upon this preliminary information. See "*Important Notice Regarding these Preliminary Financial Results and Management's Estimates*" contained in Exhibit 99.1 attached hereto.

*<u>Issuance of Press Release; KPIs for December 2022</u>*

On January 18, 2023, the Company issued a press release announcing its major Key Performance Indicators, or KPIs, updated for the month of December 2022. A copy of this press release is being furnished as Exhibit 99.2 to this Form 6-K.

Copies of the press releases being furnished as Exhibits 99.1 and 99.2 to this Form 6-K shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| [99.1](tm233747d1_ex99-1.htm) | [Press release of the Company, dated January 18, 2023, announcing the unaudited, preliminary financial results of the Company for the year ended December 31, 2022, prepared in accordance with Japanese GAAP](tm233747d1_ex99-1.htm) |
| [99.2](tm233747d1_ex99-2.htm) | [Press release of the Company, dated January 18, 2023, announcing the Company's KPIs for December 2022](tm233747d1_ex99-2.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | MEDIROM HEALTHCARE TECHNOLOGIES INC. | MEDIROM HEALTHCARE TECHNOLOGIES INC. |
| Date: January 18, 2023 |  |  |
|  | By: | */s/ Fumitoshi Fujiwara* |
|  |  | Name: Fumitoshi Fujiwara |
|  |  | Title: Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

![](tm233747d1_ex99-1img001.jpg)

**MEDIROM Healthcare Technologies Inc. Announces** 

**Preliminary, Unaudited Financial Results for Full Year 2022 under Japanese GAAP**

***Continuous Strong Revenue Growth / Turned into Operating Profitability***

New York – January 18, 2023 – MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the "Company"), today announced its preliminary, unaudited financial results for the year ended December 31, 2022, prepared under Japanese GAAP ("JGAAP"). These preliminary financial results and management's estimates included in this press release are unreviewed, unaudited, and preliminary, are prepared solely in accordance with JGAAP, have not been reviewed or audited under U.S. GAAP, and are based solely on information available to the management of the Company and management's assumptions and expectations as of the date of this press release, which remain subject to change. Actual results for the year ended December 31, 2022 remain subject to the completion of management's reviews and reconciliations and/or adjustments under U.S. GAAP, the Company's other financial closing procedures, and the audit by the independent auditor in accordance with U.S. GAAP, and may differ from these estimated preliminary results due to the completion of the Company's financial closing procedures, the audit under U.S. GAAP, and other developments that may arise during the audit process. Accordingly, you should not place undue reliance on this preliminary information. See "*Important Notice Regarding these Preliminary Financial Results and Management's Estimates*" below.

The Company is currently working with its independent registered public accounting firm to complete the audit of its financial results for the year ended December 31, 2022 in accordance with U.S. GAAP and to prepare its Annual Report on Form 20-F containing the audited financial statements for full year 2022. The Company intends to file such Annual Report by the filing deadline prescribed by the SEC.

**Preliminary Financial Results Overview for the Year Ended December 31, 2022 under JGAAP:**

• The unaudited, preliminary total revenue for the year ended December 31, 2022 is expected to be approximately JPY6.5 billion ($49.3 million)<sup>(1)</sup>, representing a projected increase of JPY1.1 billion ($8.3 million)<sup>(1)</sup> from the total revenue reported in accordance with U.S. GAAP for the year ended December 31, 2021. Such increase was primarily due to the full-year revenue contribution of two subsidiaries, SAWAN and ZACC, which were acquired by us during 2021, an increase in the revenue from sales of our directly-owned salons to investors, which sales were commenced in the fourth quarter of 2021, and an increase in sales at our directly-operated salons as a result of the recovery from COVID-19 in 2022.

• The unaudited, preliminary operating expenses are expected to be approximately JPY6.26 billion ($47.5 million)<sup>(1)</sup> for the year ended December 31, 2022, representing a projected increase of JPY380 million ($2.9 million)<sup>(1)</sup> from the operating expenses reported in accordance with U.S. GAAP for the year ended December 31, 2021. Such increase was primarily due to an increase in outsourcing fees paid to contract-based therapists, and increased payroll expense for therapists, hair dressers, and corporate staff in 2022.

• The unaudited, preliminary operating income is expected to be to approximately JPY240 million ($1.8 million)<sup>(1)</sup> for the year ended December 31, 2022, representing a projected increase of JPY711 million ($5.4 million)<sup>(1)</sup> from the operating loss reported in accordance with U.S. GAAP for the year ended December 31, 2021. Such increase was primarily due to the increase in total revenue outpacing the increase in operating expenses in 2022.

<sup>(1)</sup> Convenience translations included in this press release of Japanese yen into U.S. dollars have been made at the exchange rate of JPY131.810 = US$1.00, which was the foreign exchange rate on December 30, 2022 as reported by the Board of Governors of the Federal Reserve System in weekly release on January 3, 2023.

![](tm233747d1_ex99-1img001.jpg)

---

| | | |
|:---|:---|:---|
| | **(Japanese GAAP, UNAUDITED,<br> Preliminary numbers)\*** | **(Japanese GAAP, UNAUDITED,<br> Preliminary numbers)\*** |
| **(Millions of yen)**<br>**Consolidated Statements of Income:** | **Year Ended December 31, 2022** | **Year Ended December 31, 2022** |
| Revenue |  | 6500 |
| Operating expenses | | 6,260 |
| Operating income | | 240 |

---

\*Actual results for the year ended December 31, 2022 remain subject to the completion of management's reviews and reconciliations and/or adjustments under U.S. GAAP, the Company's other financial closing procedures, and the audit by the independent auditor in accordance with U.S. GAAP, and may differ from these estimated preliminary results due to the completion of the Company's financial closing procedures, the audit under U.S. GAAP, and other developments that may arise during the audit process. Accordingly, you should not place undue reliance on these preliminary results. See "*Important Notice Regarding these Preliminary Financial Results and Management's Estimates*" below.

**Key Performance Indicators, or KPIs, for the Year Ended December 31, 2022:**

The Company reported major Key Performance Indicators, or KPIs, for the year ended December 31, 2022. Data is provided for all salons for which comparative financial and customer data is available and excludes certain salons where such information is not available.

● The total number of salons was 312 in December 2022, which remained the same as that of December 2021.

● Total customers served was 826,231 for the year ended December 31, 2022, an increase from 781,438 for the year ended December 31, 2021.

● Average sales per customer was JPY 6,627 for the year ended December 31, 2022, an increase from JPY 6,445 in the year ended December 31, 2021.

● Average repeat ratio, a measure of repeat customers, was 81.5% for the year ended December 31, 2022, which remained stable as compared to 81.9% for the year ended December 31, 2021.

● Average operation ratio was 49.2% for the year ended December 31, 2022, an increase from 47.6% for the year ended December 31, 2021.

● The total number of salons with data increased to 231 in December 2022 from 221 in December 2021.

**Management Discussion**

Kouji Eguchi, CEO of the MEDIROM Healthcare Technologies, said, "We are pleased with the revenue growth and improved operating income achieved under local GAAP during the year ended December 31, 2022, based on the unaudited, preliminary financial results prepared under JGAAP. Our directly-operated salons and our franchised salons contributed in very complementary ways to the strong operational results of the year, as well as the growth of the sales of directly-owned salons to investors, which has become our new revenue model. In addition, the revenue contribution from our acquired salons, which reflected the implementation of our M&A strategy, coupled with the encouraging recovery from COVID-19, led to a steady operating performance this year. Although COVID-19 continued to have an impact on the general economy in 2022, the entire MEDIROM team coalesced around our goals and were able to mitigate the impact and finish the year on a strong note. We intend to work diligently with our independent auditor to complete the audit of our 2022 financial results under U.S. GAAP. We hope to continue our growth momentum in 2023."

![](tm233747d1_ex99-1img001.jpg)

**Important Notice Regarding these Preliminary Financial Results and Management's Estimates**

The preliminary financial results and management's estimates included in this press release are unreviewed, unaudited, and preliminary, are prepared solely in accordance with JGAAP, have not been reviewed or audited under U.S. GAAP, and do not present all information necessary for an understanding of the Company's results of operations for the year ended December 31, 2022. These preliminary financial results for the year ended December 31, 2022 and management's estimates presented in this press release are based solely on information available to the management of the Company and management's assumptions and expectations as of the date of this press release, which remain subject to change. Actual results for the year ended December 31, 2022 remain subject to the completion of management's reviews and reconciliations and/or adjustments under U.S. GAAP, the Company's other financial closing procedures, and the audit by the independent auditor in accordance with U.S. GAAP, and may differ from these estimated preliminary results due to the completion of the Company's financial closing procedures, the audit under U.S. GAAP, and other developments that may arise during the audit process.

The Company expects the actual results may differ from these preliminary results contained in this press release in revenue recognition of franchise membership fees (as-billed basis in this preliminary result while as-earned basis during the estimated franchising periods after conversion) when converted from JGAAP into U.S. GAAP, the impact of which, based upon management's current assumption and estimates, is believed to be insignificant. Other potential changes from the these preliminary financial results could result from the conversion into U.S. GAAP , among others, of the following line items: (1) recognition of impairment losses on our long-lived salon assets; (2) recognition of impairment losses on our goodwill and other intangible assets; (3) increase/decrease in allowance or provisional expenses; (4) increase/decrease in cost of goods sold or inventories, particularly those related to MOTHER Bracelet<sup>Ⓡ</sup>, which are currently calculated based on standard costs and subject to adjustments into actual costs primarily due to changes in foreign currency exchange rates.

The preliminary financial results for the year ended December 31, 2022 included in this press release have been prepared by and are the responsibility of the Company's management. The Company's independent auditor has not audited, reviewed, compiled, or performed any procedures with respect to the preliminary financial results presented in this press release either under JGAAP or U.S. GAAP. Accordingly, the Company's independent auditor does not express an opinion or any other form of assurance with respect thereto.

The Company intends to file its Annual Report on Form 20-F containing the audited financial statements for the year ended December 31, 2022 prepared in accordance with U.S. GAAP by the filing deadline prescribed by the SEC, and such financial information for 2022 contained in the Annual Report, including the audited the Company's financial statements prepared in accordance with U.S. GAAP, may differ from those disclosed in this preliminary annual results press release. As such, these estimates should not be viewed as a substitute for the Company's audited annual financial statements prepared in accordance with U.S. GAAP and are not necessarily indicative of any future period. Accordingly, you should not place undue reliance on this preliminary information.

![](tm233747d1_ex99-1img001.jpg)

**About MEDIROM Healthcare Technologies Inc.**

![](tm233747d1_ex99-1img002.jpg)

MEDIROM operates 312 (as of December 31, 2022) relaxation salons across Japan, Re.Ra.Ku<sup>Ⓡ</sup>, being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health-tech business, and launched new healthcare programs using on-demand training app called "Lav<sup>Ⓡ</sup>", which is developed by the company. MEDIROM also entered the device business in 2020 and started mass production and shipments of a smart tracker "MOTHER Bracelet<sup>Ⓡ</sup>". MEDIROM plans to expand the scope of its business to include data analysis utilizing the data it has collected since formation of the company.

**Forward-Looking Statements**

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements, particularly the statements with respect to the Company's audit process, the anticipated completion of the audit, and the timing of the filing of the Company's Annual Report on Form 20-F, relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.

URL: https://medirom.co.jp/en

Contacts:

Investor Relations Team

<u>ir@medirom.co.jp</u>

## Exhibit 99.2

**Exhibit 99.2**

![](tm233747d1_ex99-2img006.jpg)

**MEDIROM Healthcare Technologies Inc. Announces December 2022** 

**Key Performance Indicators (KPIs)**

***Total Customers Served: 66,571 – Sales Per Customer: JPY 6,913 – Customer Repeat Ratio: 82.8%***

New York/January 18, 2023 – MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the "Company"), today announced its major Key Performance Indicators, or KPIs, updated for the month of December 2022. Data is provided for all salons for which comparative financial and customer data is available and excludes certain salons where such information is not available.

The following monthly KPIs provide insight into the business fundamentals and progress of the Company, updated for the month of December 2022.

· The
 number of salons was 312 in December 2022, the same as in the year-ago period.

· Total
 customers served decreased to 66,571 in December 2022 from 71,173 in the year-ago period.

· Sales
 per customer increased to JPY 6,913 in December 2022 from JPY 6,634 in December 2021. The
 increase is primarily attributed to the upselling of value-added optional services.

· Repeat
 ratio, a measure of repeat customers, increased to 82.8% in December 2022 from 81.7% in the
 year-ago period.

· Operation
 ratio decreased to 50.1% in December 2022 from 50.5% in the year-ago period.

· The
 total number of salons with data increased to 231 in December 2022 from 221 in December 2021.
 The increase is attributed to the completion of the replacement of the customer management
 system in certain salons. The number of salons with data decreases when we close salons with
 data available and increases as we open salons with such data.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;Number of<br> Salons <sup>(\*1)</sup> | &nbsp;&nbsp;Number of<br> Salons with <br> Data <sup>(\*2)</sup> | &nbsp;&nbsp;Total Customers <br> Served <sup>(\*3)</sup> | &nbsp;&nbsp;Sales per<br> Customer <sup>(\*4)</sup> | &nbsp;&nbsp;Repeat Ratio <sup>(\*5)</sup> | &nbsp;&nbsp;Operation Ratio <sup>(\*6)</sup> |
| &nbsp;&nbsp;December-21 | &nbsp;&nbsp;312 | &nbsp;&nbsp;221 | &nbsp;&nbsp;71173 | &nbsp;&nbsp;JPY 6,634 | &nbsp;&nbsp;81.7% | &nbsp;&nbsp;50.5% |
| &nbsp;&nbsp;January-22 | &nbsp;&nbsp;312 | &nbsp;&nbsp;221 | &nbsp;&nbsp;62747 | &nbsp;&nbsp;JPY 6,570 | &nbsp;&nbsp;82.4% | &nbsp;&nbsp;48.2% |
| &nbsp;&nbsp;February-22 | &nbsp;&nbsp;310 | &nbsp;&nbsp;219 | &nbsp;&nbsp;54443 | &nbsp;&nbsp;JPY 6,662 | &nbsp;&nbsp;83.8% | &nbsp;&nbsp;46.4% |
| &nbsp;&nbsp;March-22 | &nbsp;&nbsp;310 | &nbsp;&nbsp;217 | &nbsp;&nbsp;61417 | &nbsp;&nbsp;JPY 6,595 | &nbsp;&nbsp;82.4% | &nbsp;&nbsp;46.5% |
| &nbsp;&nbsp;April-22 | &nbsp;&nbsp;309 | &nbsp;&nbsp;232 | &nbsp;&nbsp;69986 | &nbsp;&nbsp;JPY 6,616 | &nbsp;&nbsp;82.0% | &nbsp;&nbsp;48.3% |
| &nbsp;&nbsp;May-22 | &nbsp;&nbsp;308 | &nbsp;&nbsp;232 | &nbsp;&nbsp;77291 | &nbsp;&nbsp;JPY 6,461 | &nbsp;&nbsp;79.6% | &nbsp;&nbsp;50.1% |
| &nbsp;&nbsp;June-22 | &nbsp;&nbsp;307 | &nbsp;&nbsp;231 | &nbsp;&nbsp;73259 | &nbsp;&nbsp;JPY 6,511 | &nbsp;&nbsp;80.4% | &nbsp;&nbsp;50.3% |
| &nbsp;&nbsp;July-22 | &nbsp;&nbsp;309 | &nbsp;&nbsp;231 | &nbsp;&nbsp;76521 | &nbsp;&nbsp;JPY 6,668 | &nbsp;&nbsp;80.6% | &nbsp;&nbsp;50.3% |
| &nbsp;&nbsp;August-22 | &nbsp;&nbsp;311 | &nbsp;&nbsp;232 | &nbsp;&nbsp;72250 | &nbsp;&nbsp;JPY 6,705 | &nbsp;&nbsp;80.1% | &nbsp;&nbsp;49.8% |
| &nbsp;&nbsp;September-22 | &nbsp;&nbsp;312 | &nbsp;&nbsp;233 | &nbsp;&nbsp;71770 | &nbsp;&nbsp;JPY 6,505 | &nbsp;&nbsp;80.8% | &nbsp;&nbsp;50.3% |
| &nbsp;&nbsp;October-22 | &nbsp;&nbsp;313 | &nbsp;&nbsp;234 | &nbsp;&nbsp;72252 | &nbsp;&nbsp;JPY 6,630 | &nbsp;&nbsp;81.8% | &nbsp;&nbsp;50.0% |
| &nbsp;&nbsp;November-22 | &nbsp;&nbsp;312 | &nbsp;&nbsp;232 | &nbsp;&nbsp;65724 | &nbsp;&nbsp;JPY 6,717 | &nbsp;&nbsp;82.6% | &nbsp;&nbsp;48.8% |
| &nbsp;&nbsp;December-22 | &nbsp;&nbsp;312 | &nbsp;&nbsp;231 | &nbsp;&nbsp;66571 | &nbsp;&nbsp;JPY 6,913 | &nbsp;&nbsp;82.8% | &nbsp;&nbsp;50.1% |

---

![](tm233747d1_ex99-2img006.jpg)

(\*1) Number of Salons: Includes our directly-operated salons and franchisees' salons.

(\*2) Number of Salons with Data: The number of salons for which comparable financial and customer data is available.

(\*3) Total Customers Served: The number of customers served at salons for which comparative financial and customer data is available.

(\*4) Sales Per Customer: The ratio of total salon sales to number of treated customers at all salons for which comparable financial and customer data is available.

(\*5) Repeat Ratio: The ratio of repeat customer visits to total customer visits in the applicable month for all salons for which comparable financial and customer data is available.

(\*6) Operation Ratio: The ratio of therapists' in-service time to total therapists' working hours (including stand-by time) for the applicable month for all salons for which comparable financial and customer data is available.

![](tm233747d1_ex99-2img001.jpg)

![](tm233747d1_ex99-2img002.jpg)

![](tm233747d1_ex99-2img006.jpg)

![](tm233747d1_ex99-2img003.jpg)

![](tm233747d1_ex99-2img004.jpg)

![](tm233747d1_ex99-2img005.jpg)

\*Since July 2021, the salon operation business has been managed by Wing Inc., which is a wholly-owned subsidiary of the Company.

![](tm233747d1_ex99-2img006.jpg)

**About MEDIROM Healthcare Technologies Inc.**

MEDIROM, a holistic healthcare company, operates 312 (as of December 31, 2022) relaxation salons across Japan, Re.Ra.Ku<sup>®</sup>, being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business, and launched new healthcare programs using on-demand training app called "Lav<sup>®</sup>", which is developed by the Company. MEDIROM also entered the device business in 2020 and has developed a smart tracker "MOTHER Bracelet<sup>®</sup>". MEDIROM hopes that its diverse health related services and products offering will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit <u>https://medirom.co.jp/en</u>

**Forward-Looking Statements**

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.

■Contacts

Investor Relations Team

<u>ir@medirom.co.jp</u>